Evidence map›Paper›PMID 37207894›Full record

ReviewMolecular and cellular neurosciences2023

Sex differences in susceptibility to substance use disorder: Role for X chromosome inactivation and escape?

Kate Krueger, Felipe Lamenza, Howard Gu, Heithem El-Hodiri, Jason Wester, John Oberdick, Andy J Fischer, Steve Oghumu

Open access · greenAbstract readReview
In one paragraph

Review in Molecular and cellular neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. ESG-1-60 and ESG-1-61: Novel dopamine DBritish journal of pharmacology · 2025
    Article
  4. Article
  5. Review
  6. Differential Effect of Chronic Morphine on Neuronal Degeneration in Male vs. Female Mice.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kate KruegerDepartment of Pharmacy, The Ohio State University, Columbus, OH, USA.
Felipe LamenzaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Department of Microbiology, The Ohio State University, Columbus, OH, USA.
Howard GuDepartment of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, USA.
Heithem El-HodiriDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA.
Jason WesterDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA.
John OberdickDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA.
Andy J FischerDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA.
Steve OghumuDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: oghumu.1@osu.edu.
The Ohio State University · USThe Ohio State University Wexner Medical Center · US

Funding

X chromosome inactivation in sex disparities to substance use disorderDP1DA054344 · NIDA · OHIO STATE UNIVERSITY · PI Steve Onyeka Oghumu · 2021 to 2026
$2.4M
NIDA NIH HHS DP1 DA054344
6 · The paper itself

Abstract

There is a sex-based disparity associated with substance use disorders (SUDs) as demonstrated by clinical and preclinical studies. Females are known to escalate from initial drug use to compulsive drug-taking behavior (telescoping) more rapidly, and experience greater negative withdrawal effects than males. Although these biological differences have largely been attributed to sex hormones, there is evidence for non-hormonal factors, such as the influence of the sex chromosome, which underlie sex disparities in addiction behavior. However, genetic and epigenetic mechanisms underlying sex chromosome influences on substance abuse behavior are not completely understood. In this review, we discuss the role that escape from X-chromosome inactivation (XCI) in females plays in sex-associated differences in addiction behavior. Females have two X chromosomes (XX), and during XCI, one X chromosome is randomly chosen to be transcriptionally silenced. However, some X-linked genes escape XCI and display biallelic gene expression. We generated a mouse model using an X-linked gene specific bicistronic dual reporter mouse as a tool to visualize allelic usage and measure XCI escape in a cell specific manner. Our results revealed a previously undiscovered X-linked gene XCI escaper (CXCR3), which is variable and cell type dependent. This illustrates the highly complex and context dependent nature of XCI escape which is largely understudied in the context of SUD. Novel approaches such as single cell RNA sequencing will provide a global molecular landscape and impact of XCI escape in addiction and facilitate our understanding of the contribution of XCI escape to sex disparities in SUD.

Indexed as

Substance-Related DisordersX Chromosome InactivationAllelesAnimalsFemaleGenes, X-LinkedMaleMiceSex CharacteristicsAddictionEpigeneticSubstance use disorderX chromosome inactivation

Identifiers

PMID37207894
PMCPMC10286730
OpenAlexW4376866822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.